Calvin H. Yeh

1.4k total citations
16 papers, 851 citations indexed

About

Calvin H. Yeh is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Infectious Diseases. According to data from OpenAlex, Calvin H. Yeh has authored 16 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Internal Medicine and 4 papers in Infectious Diseases. Recurrent topics in Calvin H. Yeh's work include Venous Thromboembolism Diagnosis and Management (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and COVID-19 Clinical Research Studies (4 papers). Calvin H. Yeh is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and COVID-19 Clinical Research Studies (4 papers). Calvin H. Yeh collaborates with scholars based in Canada, United States and Australia. Calvin H. Yeh's co-authors include Jeffrey I. Weitz, Vitaly Napadow, Rupali P. Dhond, Norman W. Kettner, Kyungmo Park, Kerstin Hogg, Peter L. Gross, James C. Fredenburgh, Brent Thoma and Teresa M. Chan and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Calvin H. Yeh

16 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Calvin H. Yeh Canada 12 267 223 177 117 113 16 851
Hae Sun Suh South Korea 17 113 0.4× 25 0.1× 33 0.2× 31 0.3× 13 0.1× 100 820
Chana A. Sacks United States 17 120 0.4× 30 0.1× 7 0.0× 35 0.3× 7 0.1× 71 760
Gonçalo S. Duarte Portugal 20 103 0.4× 17 0.1× 12 0.1× 84 0.7× 12 0.1× 54 1.2k
Simon Sanderson United Kingdom 11 211 0.8× 59 0.3× 3 0.0× 19 0.2× 41 0.4× 18 1.0k
Emily Reynen Canada 10 42 0.2× 15 0.1× 14 0.1× 25 0.2× 43 0.4× 15 747
Michele Robertson United Kingdom 23 1.1k 4.3× 83 0.4× 26 0.1× 3 0.0× 119 1.1× 41 2.0k
Hisashi Urushihara Japan 15 85 0.3× 15 0.1× 12 0.1× 24 0.2× 11 0.1× 73 828
A. Millier France 19 136 0.5× 35 0.2× 9 0.1× 44 0.4× 3 0.0× 86 1.2k
Naomi Ito Japan 15 142 0.5× 9 0.0× 12 0.1× 16 0.1× 19 0.2× 52 770
Dolores Montero Spain 16 125 0.5× 28 0.1× 9 0.1× 9 0.1× 148 1.3× 35 1.3k

Countries citing papers authored by Calvin H. Yeh

Since Specialization
Citations

This map shows the geographic impact of Calvin H. Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin H. Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin H. Yeh more than expected).

Fields of papers citing papers by Calvin H. Yeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calvin H. Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin H. Yeh. The network helps show where Calvin H. Yeh may publish in the future.

Co-authorship network of co-authors of Calvin H. Yeh

This figure shows the co-authorship network connecting the top 25 collaborators of Calvin H. Yeh. A scholar is included among the top collaborators of Calvin H. Yeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin H. Yeh. Calvin H. Yeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fraser, Douglas D., Maitray A. Patel, Logan R. Van Nynatten, et al.. (2022). Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients. Heliyon. 9(1). e12704–e12704. 4 indexed citations
2.
Yeh, Calvin H., Bettina E. Hansen, Joel O. Abraham, et al.. (2021). Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study. Journal of Thrombosis and Haemostasis. 19(6). 1546–1557. 45 indexed citations
3.
Abdel‐Qadir, Husam, Peter C. Austin, Andrea Pang, et al.. (2021). The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study. Thrombosis Research. 211. 114–122. 5 indexed citations
4.
Yeh, Calvin H., Kerstin de Wit, Jerrold H. Levy, et al.. (2020). Hypercoagulability and coronavirus disease 2019–associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms. The Journal of Trauma: Injury, Infection, and Critical Care. 89(6). e177–e181. 6 indexed citations
5.
Huang, Simon, Lynsey J. Martin, Calvin H. Yeh, et al.. (2018). The effect of an infographic promotion on research dissemination and readership: A randomized controlled trial. Canadian Journal of Emergency Medicine. 20(6). 826–833. 52 indexed citations
6.
Chan, Teresa M., Andrew W. Shih, Vinai Bhagirath, et al.. (2018). The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series. Perspectives on Medical Education. 7(3). 219–223. 13 indexed citations
7.
Yeh, Calvin H., et al.. (2018). Massive hemorrhage protocol survey: Marked variability and absent in one-third of hospitals in Ontario, Canada. Injury. 50(1). 46–53. 8 indexed citations
8.
Yeh, Calvin H., Brian Dale, Beverly A. Leslie, et al.. (2018). Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation. SHILAP Revista de lepidopterología. 2(2). e190–e201. 18 indexed citations
9.
Thoma, Brent, Heather Murray, Simon Huang, et al.. (2017). The impact of social media promotion with infographics and podcasts on research dissemination and readership. Canadian Journal of Emergency Medicine. 20(2). 300–306. 95 indexed citations
10.
Stafford, Alan R., Chengliang Wu, Calvin H. Yeh, et al.. (2017). Exosite 2-Directed Ligands Attenuate Protein C Activation by the Thrombin–Thrombomodulin Complex. Biochemistry. 56(24). 3119–3128. 14 indexed citations
11.
Yeh, Calvin H., Alan R. Stafford, Beverly A. Leslie, James C. Fredenburgh, & Jeffrey I. Weitz. (2016). Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function. PLoS ONE. 11(6). e0157471–e0157471. 15 indexed citations
12.
Yeh, Calvin H., Kerstin Hogg, & Jeffrey I. Weitz. (2015). Overview of the New Oral Anticoagulants. Arteriosclerosis Thrombosis and Vascular Biology. 35(5). 1056–1065. 137 indexed citations
13.
Yeh, Calvin H., Peter L. Gross, & Jeffrey I. Weitz. (2014). Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood. 124(7). 1020–1028. 108 indexed citations
14.
Yeh, Calvin H., James C. Fredenburgh, & Jeffrey I. Weitz. (2012). Oral Direct Factor Xa Inhibitors. Circulation Research. 111(8). 1069–1078. 84 indexed citations
15.
Dhond, Rupali P., Calvin H. Yeh, Kyungmo Park, Norman W. Kettner, & Vitaly Napadow. (2008). Acupuncture modulates resting state connectivity in default and sensorimotor brain networks. Pain. 136(3). 407–418. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026